These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
648 related articles for article (PubMed ID: 20303876)
41. Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease. Lopetuso LR; Petito V; Zambrano D; Orlando D; Dal Lago A; Serrichhio L; Papa A; Gasbarrini A; Scaldaferri F Dig Dis; 2016; 34(3):202-9. PubMed ID: 27028023 [TBL] [Abstract][Full Text] [Related]
42. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Sokol H; Seksik P Curr Opin Gastroenterol; 2010 Jul; 26(4):327-31. PubMed ID: 20445446 [TBL] [Abstract][Full Text] [Related]
43. The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease. Rautava S; Isolauri E Curr Issues Intest Microbiol; 2002 Mar; 3(1):15-22. PubMed ID: 12022809 [TBL] [Abstract][Full Text] [Related]
44. [Inflammatory bowel diseases and enteric microbiota]. Kim JM Korean J Gastroenterol; 2010 Jan; 55(1):4-18. PubMed ID: 20098062 [TBL] [Abstract][Full Text] [Related]
45. Functions of innate immune cells and commensal bacteria in gut homeostasis. Kayama H; Takeda K J Biochem; 2016 Feb; 159(2):141-9. PubMed ID: 26615026 [TBL] [Abstract][Full Text] [Related]
46. The effect of probiotics and gut microbiota on Th17 cells. Tanabe S Int Rev Immunol; 2013; 32(5-6):511-25. PubMed ID: 24094077 [TBL] [Abstract][Full Text] [Related]
47. Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells. Schey R; Danzer C; Mattner J Immunobiology; 2015 Feb; 220(2):227-35. PubMed ID: 25466587 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease. Andoh A; Fujiyama Y World J Gastroenterol; 2006 Jul; 12(28):4452-60. PubMed ID: 16874854 [TBL] [Abstract][Full Text] [Related]
51. Inflammatory bowel disease: is the intestine a Trojan horse? Basset C; Holton J Sci Prog; 2002; 85(Pt 1):33-56. PubMed ID: 11969118 [TBL] [Abstract][Full Text] [Related]
52. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease. Uhlig HH; Powrie F Eur J Immunol; 2009 Aug; 39(8):2021-6. PubMed ID: 19672896 [TBL] [Abstract][Full Text] [Related]
53. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again? Satokari R Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554 [TBL] [Abstract][Full Text] [Related]
54. The gut microbiota shapes intestinal immune responses during health and disease. Round JL; Mazmanian SK Nat Rev Immunol; 2009 May; 9(5):313-23. PubMed ID: 19343057 [TBL] [Abstract][Full Text] [Related]
55. Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation. Kelsall BL J Pathol; 2008 Jan; 214(2):242-59. PubMed ID: 18161750 [TBL] [Abstract][Full Text] [Related]
56. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041 [TBL] [Abstract][Full Text] [Related]
57. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. Asquith M; Powrie F J Exp Med; 2010 Aug; 207(8):1573-7. PubMed ID: 20679404 [TBL] [Abstract][Full Text] [Related]